NightWare, Inc., digital therapeutics for mental health company has received Breakthrough Status designation from the U.S. Food and Drug Administration (FDA) for its NightWare Apple Watch app that measures and treats nightmares in people with Post-Traumatic Stress Disorder (PTSD).Impact of Nightmare DisordersNightmares and Nightmare Disorder have been linked to increased suicidality, heightened risk of heart disease, diabetes, and contributes to cognitive difficulties such as memory loss,
Read More
BHE Raises $78M To Expand Real-World Evidence Analytics Platform
BHE, a Boston, MA-based innovative healthcare analytics company, today announced a $78 million minority growth investment led by Silversmith Capital Partners (“Silversmith”) and Leerink Transformation Partners (“LTP”). Instant Health DataThe use of real-world evidence (RWE) has grown rapidly within life sciences companies over the last several years, supported by the proliferation of large datasets, new computing technologies, and interest by both payers and regulatory agencies in understanding
Read More
Amgen, Syapse Partner to Develop Observational Research Analytics for Precision Oncology
Amgen, a world leader in biotechnology, and Syapse, a company powering precision medicine insights through its global provider network, today announced a precision medicine collaboration in oncology. Under the terms of the collaboration, Amgen and Syapse will develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.Generates Insights from Real-World Evidence for Potential Use in Regulatory FilingsThis effort will identify existing patients within
Read More
Digital Twin Technology: Should Healthcare Jump on the Bandwagon?
Source: The Living Heart Project
While healthcare is known for not jumping to conclusions very fast when investing in new technology, the industry starts to pick up the pace. Such “newcomers” as blockchain, IoT, VR, and AR get a well-deserved appraisal and become an integral part of next-gen custom healthcare software aimed at supporting personalized treatment and predictable patient outcomes across a wide range of conditions.
We anticipate that the digital twin technology has good chances
Read More
EMV Capital Acquires Predictive Adverse Events Platform Wanda
EMV Capital, a London-based early-stage venture investor announced the acquisition and investment in Wanda Inc., a San Francisco-based digital health startup commercializing advanced clinical decision support software powered by machine learning and real-time patient data analysis. EMV Capital’s investment will enable Wanda to accelerate its growth in the North American market, as well as to enter the UK and European markets.Wanda Inc. BackgroundWanda Founded in 2011 from the results of eight
Read More
National Cancer Institute Awards Medable $3.5M in Grants to Develop Digital Care Platforms
Medable Awarded $3.5M in SBIR Fast-Track Grants from the National Cancer Institute to Develop Digital Platforms to Improve Patient Care
The National
Cancer Institute (NCI) has awarded Medable
Inc. an end-to-end platform for digitally enabled and data-driven clinical
trials two Fast-Track Small Business Innovation (SBIR) grants. The grants will
provide up to $3.5 million in nondilutive research funding over the next
several years to develop digital platforms to improve patient
Read More
Medidata Launches New Life Sciences Company, Acorn AI
Life sciences digital transformation company Medidata, today announced the launch of Acorn AI, a new company designed to provide actionable insights across the entire drug continuum – from R&D to commercialization. In addition, the company has appointed Rama Kondru, Ph.D., as the chief information officer for Medidata and Acorn AI’s first CIO to lead the company’s enterprise data strategy, architecture and future platform development – all helping the company to accelerate the creation of
Read More
The Cost of Medical Device Innovation: Can The U.S. Keep Pace?
Over the last six years, the U.S. Food and Drug Administration has approved a number of highly innovative medical devices that have revolutionized cardiovascular care. These novel devices have provided advanced treatment options, improved quality of life and extended longevity for patients. Unfortunately, reimbursement has often failed to keep up with many of increasingly expensive treatment options, according to a new report released by Vizient. The report, The cost of medical device
Read More
Deep Lens Lands $14M to Scale AI-Driven Digital Pathology Platform
Digital pathology startup Deep Lens lands $14M in Series A funding to scale AI-driven digital pathology platform
Deep Lens, Inc., a Columbus, OH-based AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis has raised $14 million in Series A funding. The Series A round was led by Northpond Ventures with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners. The funding comes months after Deep Lens emerged
Read More
Where’s the Evidence? Barriers to Analyzing Digital Health’s Impact
The digital health industry continues to grow at an unprecedented rate. In 2018, venture funding for digital health companies approached a record $8.1B in funding, according to Rock Health. These companies are striving to address important healthcare issues by developing products and service offerings in various categories like genome sequencing, analytics, telemedicine, mobile apps, and population health management tools—all with the promise of increased insights and patient engagement, and
Read More